Logo image of HSKA

Heska Corporation (HSKA) Stock Fundamental Analysis

NASDAQ:HSKA - US42805E3062 - Common Stock

119.99 USD
+0.05 (+0.04%)
Last: 6/12/2023, 8:00:01 PM
119.99 USD
0 (0%)
After Hours: 6/12/2023, 8:00:01 PM
Fundamental Rating

3

Overall HSKA gets a fundamental rating of 3 out of 10. We evaluated HSKA against 185 industry peers in the Health Care Equipment & Supplies industry. The financial health of HSKA is average, but there are quite some concerns on its profitability. HSKA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year HSKA has reported negative net income.
HSKA had a negative operating cash flow in the past year.
HSKA had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: HSKA reported negative operating cash flow in multiple years.
HSKA Yearly Net Income VS EBIT VS OCF VS FCFHSKA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 10M -10M -20M

1.2 Ratios

The profitability ratios for HSKA are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HSKA Yearly ROA, ROE, ROICHSKA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 5 -5 10

1.3 Margins

Looking at the Gross Margin, with a value of 42.93%, HSKA is doing worse than 62.02% of the companies in the same industry.
HSKA's Gross Margin has been stable in the last couple of years.
HSKA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.86%
GM growth 5Y-0.85%
HSKA Yearly Profit, Operating, Gross MarginsHSKA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 10 20 30 40

More info and screens

5

2. Health

2.1 Basic Checks

HSKA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HSKA has been increased compared to 1 year ago.
The debt/assets ratio for HSKA has been reduced compared to a year ago.
HSKA Yearly Shares OutstandingHSKA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M 10M
HSKA Yearly Total Debt VS Total AssetsHSKA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M

2.2 Solvency

HSKA has an Altman-Z score of 4.79. This indicates that HSKA is financially healthy and has little risk of bankruptcy at the moment.
HSKA has a Altman-Z score of 4.79. This is in the better half of the industry: HSKA outperforms 75.48% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that HSKA is not too dependend on debt financing.
HSKA has a Debt to Equity ratio (0.23) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z 4.79
ROIC/WACCN/A
WACC9.05%
HSKA Yearly LT Debt VS Equity VS FCFHSKA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 5.64 indicates that HSKA has no problem at all paying its short term obligations.
The Current ratio of HSKA (5.64) is better than 70.67% of its industry peers.
A Quick Ratio of 4.12 indicates that HSKA has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.12, HSKA is in the better half of the industry, outperforming 68.27% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.64
Quick Ratio 4.12
HSKA Yearly Current Assets VS Current LiabilitesHSKA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M

More info and screens

3

3. Growth

3.1 Past

HSKA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -51.97%.
The Revenue has decreased by -1.22% in the past year.
Measured over the past years, HSKA shows a quite strong growth in Revenue. The Revenue has been growing by 14.75% on average per year.
EPS 1Y (TTM)-51.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-1.22%
Revenue growth 3Y28%
Revenue growth 5Y14.75%
Sales Q2Q%-3.73%

3.2 Future

The Earnings Per Share is expected to grow by 26.44% on average over the next years. This is a very strong growth
Based on estimates for the next years, HSKA will show a small growth in Revenue. The Revenue will grow by 7.79% on average per year.
EPS Next Y55.25%
EPS Next 2Y40.17%
EPS Next 3Y27.58%
EPS Next 5Y26.44%
Revenue Next Year9.92%
Revenue Next 2Y9.98%
Revenue Next 3Y9.67%
Revenue Next 5Y7.79%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HSKA Yearly Revenue VS EstimatesHSKA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
HSKA Yearly EPS VS EstimatesHSKA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2 -2 3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HSKA. In the last year negative earnings were reported.
Also next year HSKA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HSKA Price Earnings VS Forward Price EarningsHSKA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -500 -1K -1.5K

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HSKA Per share dataHSKA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

HSKA's earnings are expected to grow with 27.58% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.17%
EPS Next 3Y27.58%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HSKA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Heska Corporation

NASDAQ:HSKA (6/12/2023, 8:00:01 PM)

After market: 119.99 0 (0%)

119.99

+0.05 (+0.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-05 2023-05-05/bmo
Earnings (Next)08-07 2023-08-07/bmo
Inst Owners0.01%
Inst Owner Change0%
Ins Owners3.86%
Ins Owner Change0%
Market Cap1.31B
Analysts78
Price Target132.6 (10.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-496.61%
Min EPS beat(2)-904.9%
Max EPS beat(2)-88.31%
EPS beat(4)1
Avg EPS beat(4)-332.9%
Min EPS beat(4)-904.9%
Max EPS beat(4)49.4%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.2%
Min Revenue beat(2)-4.99%
Max Revenue beat(2)0.58%
Revenue beat(4)1
Avg Revenue beat(4)-5.85%
Min Revenue beat(4)-11.47%
Max Revenue beat(4)0.58%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)22.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-233.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.51%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.14
P/FCF N/A
P/OCF N/A
P/B 3.14
P/tB 6.34
EV/EBITDA N/A
EPS(TTM)-1.93
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)-1.56
FCFYN/A
OCF(TTM)-1.22
OCFYN/A
SpS23.35
BVpS38.27
TBVpS18.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.93%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.86%
GM growth 5Y-0.85%
F-Score4
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 25.03%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.64
Quick Ratio 4.12
Altman-Z 4.79
F-Score4
WACC9.05%
ROIC/WACCN/A
Cap/Depr(3y)11.41%
Cap/Depr(5y)28.94%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y55.25%
EPS Next 2Y40.17%
EPS Next 3Y27.58%
EPS Next 5Y26.44%
Revenue 1Y (TTM)-1.22%
Revenue growth 3Y28%
Revenue growth 5Y14.75%
Sales Q2Q%-3.73%
Revenue Next Year9.92%
Revenue Next 2Y9.98%
Revenue Next 3Y9.67%
Revenue Next 5Y7.79%
EBIT growth 1Y-43.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year269.41%
EBIT Next 3Y72.39%
EBIT Next 5YN/A
FCF growth 1Y-461.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-344.65%
OCF growth 3YN/A
OCF growth 5YN/A